Rethinking Regulatory Agencies and Healthcare Innovation

The chapter critically examines the role and impact of regulatory agencies such as the FDA and CDC on various healthcare issues, questioning their effectiveness and influence on innovation. Discussions include the implications of FDA regulations on drug development, the potential harm of mandates, and the concept of alternative institutions for product safety.